Cyxtera Results Presentation Deck slide image

Cyxtera Results Presentation Deck

Transaction Adjusted EBITDA Bridge: Q1 2022 to Q1 2023 ($ in Millions) Cyxtera $58.6 Q1'22 +$14.3 Change in Revenue -$5.8 Change in Cost of Revenue -$10.9 Change in SG&A + $7.0 Change in Adjustments (1)(2) $63.3 Q1'23 (1) Includes pro forma EBITDA adjustments related to one-time stand-up costs, recurring expenses, restructuring & cost-savings initiatives, as well as product development & start-up costs (2) Excludes $278.2M Goodwill Impairment and $4.5 in restructuring, impairment, site closures and related cost in Q1'23 and excludes $11.8M benefit related to change in fair value of derivative liabilities, offset by $1.4M in restructuring, impairment, site closures and related cost. 11
View entire presentation